Oral Ulcer: Clinical Trials

16 trials for Oral Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 6 completed, 2 terminated, 1 recruiting. 16 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 216Unknown 7, Completed 6, Terminated 2, Recruiting 1
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 12Completed 1, Unknown 1

Follow Oral Ulcer: new trials by email Literature Review of Oral Ulcer trials Research Report on Oral Ulcer

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous Ulcers
Rebamipide mouthwash, Betamethasone mouthwash - Oral Aphthous Ulcers
Phase 2RecruitingCairo University462026-07-012026-10-06
Mucoadhesive Film With/without Acmella Oleracea & Triamcinolone Acetonide for Aphthous Ulcers
mucoadhesive film with Acmella oleracea extract, Triamcinolone Acetonide 0.1% Oromucosal Paste, mucoadhesive film without Acmella oleracea extract - Aphthous Stomatitis
Phase 2UnknownKhon Kaen University722024-10-152024-10-02
Study for the Prevention of Oral Mucositis (SPOM)
Bocaliner, Benzydamine - Oral Mucositis
Phase 1 / Phase 2UnknownE2Bio Life Sciences, LLC1002022-04-152023-09-08
Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.
Dentoxol mouthrinse dosages - Epidermolysis Bullosa, Oral Ulcer
Phase 2UnknownUniversity of Chile1002022-04-062022-04-14
Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers
mouthwash with tea - Stomatitis
Phase 2UnknownChang Gung Memorial Hospital1002021-08-262021-08-18
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.
Clonidine HCl Mucoadhesive Buccal Tablet, Placebo Mucoadhesive Buccal Tablet - Chemoradiotherapy-Induced Severe Oral Mucositis
Phase 2 / Phase 3TerminatedMonopar Therapeutics1902021-02-112023-05-31
Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis
use of basil extract gel in treatment of aphthus ulcer, muco adhesive placebo gel, no treatment - Oral Ulcer
Phase 2UnknownTanta University302021-01-012021-07-14
Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology
Ustekinumab - LAD1
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)62018-07-022024-10-22
Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions.
Ibuprofen suspension 5mg/100ml, Placebos - Oral Lichen Planus, Oral Lichenoid Mucositis
Phase 2 / Phase 3CompletedUniversity of Washington232018-04-292020-05-08
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
Miracle Mouthwash Plus Hydrocortisone, Prednisolone - Stomatitis, Oral Mucositis
Phase 2CompletedUS Oncology Research1042014-09-042022-12-01
Tocilizumab for the Treatment of Behcet's Syndrome
Tocilizumab - Behcet Syndrome
Phase 2TerminatedNYU Langone Health12012-09-012019-02-15
Diet and Lifestyle Intervention Study in Postpartum Women in China
Diet and Lifestyle Intervention in Chinese Postpartum Women - Puerperal Infection, Fever
Phase 2 / Phase 3UnknownHuazhong University of Science and Technology16002009-06-012009-12-24
Efficacy of 5% Chitosan Nanoparticle Paste in the Treatment of Recurrent Aphthous Stomatitis
Triamcinolone Acetonide 0.1% Oral Paste, 5 wt.% Chitosan Nanoparticle Paste - Recurrent Aphthous Stomatitis, Oral Ulcers
Phase 2CompletedKerman University of Medical Sciences302009-04-212026-07-14
Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae
Prednisolone, Colchicine - Oral Aphthae
Phase 2UnknownMashhad University of Medical Sciences302007-05-012008-07-29
Safety and Efficacy of RK0202 in Oral Mucositis
RK-0202 - Mouth Diseases, Mouth Ulcers
Phase 2CompletedRxKinetix1102003-01-012007-01-15
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
Thalidomide - Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome
Phase 2CompletedNational Institute of Dental and Craniofacial Research (NIDCR)1101996-06-012008-03-04

Narrower conditions

Stomatitis (5)  ·  Stomatitis, Aphthous (4)  ·  Foot-and-Mouth Disease (2)  ·  Head and Neck Neoplasms (2)  ·  Mucositis (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anemia (1)  ·  Behcet Syndrome (1)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Burning Mouth Syndrome (1)  ·  Constipation (1)  ·  Epidermolysis Bullosa (1)  ·  Fever (1)

Broader conditions

Stomatognathic Diseases (16)  ·  Mouth Diseases (15)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Infections (4)  ·  Stomatitis (4)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Animal Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)

Interventions

Anti-Inflammatory Agents (2)  ·  Prednisolone (2)  ·  Triamcinolone Acetonide (2)  ·  Benzydamine (1)  ·  Betamethasone (1)  ·  Colchicine (1)  ·  Diet (1)  ·  Gramicidin, Neomycin Sulfate, Nystatin, Triamcinolone Acetonide Drug Combination (1)  ·  Hydrocortisone (1)  ·  Methylprednisolone (1)  ·  Mouthwashes (1)  ·  Multicenter Studies as Topic (1)  ·  Ointments (1)  ·  Suspensions (1)  ·  Tea (1)

Sponsors

Cairo University (1)  ·  Chang Gung Memorial Hospital (1)  ·  E2Bio Life Sciences, LLC (1)  ·  Huazhong University of Science and Technology (1)  ·  Kerman University of Medical Sciences (1)  ·  Khon Kaen University (1)  ·  Mashhad University of Medical Sciences (1)  ·  Monopar Therapeutics (1)  ·  NYU Langone Health (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  RxKinetix (1)  ·  Tanta University (1)  ·  US Oncology Research (1)  ·  University of Chile (1)

Countries

United States (7)  ·  Egypt (2)  ·  Armenia (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Andy Trotti, MD (1)  ·  Beatriz E Marciano, M.D. (1)  ·  Donald Welsh, MD (1)  ·  Doug Peterson, DMD (1)  ·  Guy Juillard, MD (1)  ·  Holli Carlson (1)  ·  Jim Wright, MD (1)  ·  John Feldmeier, DO (1)  ·  Joyce A. O'Shaughnessy, MD (1)  ·  Kemporn Kitsahawong, Ph.D (1)  ·  Liegang Liu, PhD (1)  ·  Mark Chambers, DMD MS (1)  ·  Rufus Scrimger, MD (1)  ·  Samy El Sayed, MD (1)  ·  Steve Sonis, DMD DMSc (1)

Results publications

PMID 20187965, PMID 40268883, PMID 40742572

NIH funding

D43DE032294 (1)